GE, Intel deal crosses the pond
GE Healthcare and Intel have expanded their sales and marketing agreement for the Intel Health Guide to include the U.K. GE already markets the Intel Health Guide in the U.S.
The companies said that the Intel Health Guide is a care management tool designed for healthcare professionals who manage patients with chronic conditions such as diabetes, hypertension, chronic obstructive pulmonary disease and heart failure. GE’s capabilities in disease management include patients’ self-monitoring of health status and a direct communications channel to healthcare professionals.
The announcement also expands GE’s Home Health business in the U.K. With 3,000 employees in the U.K., GE said it provides technologies for patient monitoring and diagnosis of disease, and has provided services to the NHS and the U.K. private health sector for more than 30 years.
GE said its Home Health business in the U.K. will be managed by Richard Rees-Davies.
The companies said that the Intel Health Guide is a care management tool designed for healthcare professionals who manage patients with chronic conditions such as diabetes, hypertension, chronic obstructive pulmonary disease and heart failure. GE’s capabilities in disease management include patients’ self-monitoring of health status and a direct communications channel to healthcare professionals.
The announcement also expands GE’s Home Health business in the U.K. With 3,000 employees in the U.K., GE said it provides technologies for patient monitoring and diagnosis of disease, and has provided services to the NHS and the U.K. private health sector for more than 30 years.
GE said its Home Health business in the U.K. will be managed by Richard Rees-Davies.